155
Views
2
CrossRef citations to date
0
Altmetric
Original Research

Seropositivity of West Nile Virus Among Acute Febrile Patients in Southern Ethiopia

ORCID Icon, , &
Pages 1491-1497 | Published online: 20 May 2020

References

  • Shomaker TS, Green EM, Yandow SM. Perspective. One Health: a compelling convergence. Acad Med. 2013;88(1):49–55. doi:10.1097/ACM.0b013e31827651b123165268
  • Campbell GL, Marfin AA, Lanciotti RS, Gubler DJ. West Nile virus. Lancet Infect Dis. 2002;2(9):519–529. doi:10.1016/S1473-3099(02)00368-712206968
  • Smithburn KC, Hughes TP, Burke AW, Paul JH, African A. A neurotropic virus isolated from the blood of a native of Uganda. Am J Trop Med Hyg. 1940;s1-20:471–492.
  • Murgue B, Murri S, Triki H, Deubel V, Zeller HG. West Nile in the Mediterranean basin: 1950–2000. Ann N Y Acad Sci. 2001;951:117–126. doi:10.1111/j.1749-6632.2001.tb02690.x11797769
  • Urgue B, Zeller H, Deubel V. The ecology and epidemiology of West Nile Virus in Africa, Europe and Asia In Japanese encephalities and west nile viruses 2002 (pp 195-221): Springer Berlin Heidelberg.
  • Huba´lek Z, Halouzka J. West Nile fever-a reemerging mosquito-borne viral disease in Europe. Emerg Infect Dis. 1999;5:643–650. doi:10.3201/eid0505.99050510511520
  • Asnis DS, Conetta R, Waldman G, Teixera AA.The West Nile Virus encephalitis outbreak in theUnited States (1999–2000). Ann N Y Acad Sci.2006;951:161–171. doi:10.1111/j.1749-6632.2001.tb02694.x
  • Nash D, Mostashari F, Fine A, Miller J, O'Leary D, Murray K, et al. The outbreak of West Nile Virus infection in the New York City Area in 1999. N Engl J Med. 2001;344:1807–1814. doi:10.1056/NEJM20010614344240111407341
  • Rossi SL, Ross TM, Evans JD. West Nile Virus. Clin Lab Med. 2010;30:47–65. doi:10.1016/j.cll.2009.10.00620513541
  • Tsai T, Popovici F, Cernescu C, Campbell G, Nedelcu N. West nile encephalitis epidemic in southeastern Romania. Lancet. 1998;352:767–771.9737281
  • Platonov AE, Shipulin GA, Shipulina OY, et al. Outbreak of West Nile virus infection, Volgograd Region, Russia, 1999. Emerg Infect Dis. 2001;7:128–132. doi:10.3201/eid0701.01011811266303
  • Sambri V, Capobianchi M, Charrel R, et al. West Nile virus in Europe: emergence, epidemiology, diagnosis, treatment, and prevention. Clin Microbiol Infect. 2013;19:699–704. doi:10.1111/1469-0691.1221123594175
  • Hayes EB, Sejvar JJ, Zaki SR, Lanciotti RS, Bode AV, Campbell GL. Virology, pathology, and clinical manifestations of West Nile virus disease. Emerg Infect Dis. 2005;11:1174–1179. doi:10.3201/eid1108.050289b16102303
  • Kramer LD, Li J, Shi P-Y. West Nile virus. Lancet Neurol. 2007;6:171–181. doi:10.1016/S1474-4422(07)70030-317239804
  • Suthar MS, Diamond MS, Jr GM. West Nile virus infection and immunity. Nat Rev Microbiol. 2013;11:115–128. doi:10.1038/nrmicro295023321534
  • West Nile Virus Activity-United States, 2006. JAMA. 2007;298:619. doi:10.1001/jama.298.6.619
  • Chowers MY, Lang R, Nassar F, Ben-David D, Giladi M, Rubinshtein E, et al. Clinical characteristics of the West Nile fever outbreak, Israel, 2000. Emerging infectious diseases. 2001;7(4):675. doi:10.3201/eid0704.01041411585531
  • Petersen LR, Marfin AA. West Nile Virus. A primer for the clinician. Ann Intern Med. 2002;137:173–179. doi:10.7326/0003-4819-137-3-200208060-0000912160365
  • May FJ, Davis CT, Tesh RB, Barrett AD. Phylogeography of West Nile virus. J Virol. 2011;85(6):2964–2974. doi:10.1128/JVI.01963-1021159871
  • Murray KO, Mertens E, Despres P. West Nile virus and its emergence in the United States of America. Vet Res. 2010;41:67. doi:10.1051/vetres/201003921188801
  • Lanciotti RS, Roehrig JT, Deubel V, et al. Origin of the West Nile Virus responsible for an outbreak of encephalitis in the Northeastern United States. Science. 1999;286:2333–2337. doi:10.1126/science.286.5448.233310600742
  • Patel H, Sander B, Nelder MP. Long-term sequelae of West Nile virus-related illness: a systematic review. Lancet Infect Dis. 2015;15(8):951–959. doi:10.1016/S1473-3099(15)00134-626163373
  • Tsegaye MM, Beyene B, Ayele W, et al. Sero-prevalence of yellow fever and related Flaviviruses in Ethiopia: a public health perspective. BMC Public Health. 2018;18(1):1011. doi:10.1186/s12889-018-5726-930107830
  • Chepkorir E, Tchouassi DP, Konongoi SL, et al. Serological evidence of Flavivirus circulation in human populations in Northern Kenya: an assessment of disease risk 2016–2017. Virol J. 2019;16(1):65. doi:10.1186/s12985-019-1176-y31101058
  • Kolawole OM, Adelaide G, Emergence O. Associated Risk Factors of Vector-Borne West Nile Virus Infection in Ilorin, Nigeria. J Arthropod Borne Dis. 2018;12(4):341–350.30918903
  • Inziani M, Adungo F, Awando J, et al. Seroprevalence of yellow fever, dengue, West Nile and chikungunya viruses in children in Teso South Sub-County, Western Kenya. Int J Infect Dis. 2020;9:104–110. doi:10.1016/j.ijid.2019.11.004
  • Sule WF, Oluwayelu DO. Serologic Evidence of Exposure to West Nile Virus among Humans in Ibadan, Southwestern Nigeria. Sudan JMS. 2016;11(3):111–123.
  • Baba MM, Saron MF, Diop O, Mathiot C, Adeniji JA, Olaleye OD. West Nile virus in mosquitoes and febrile patients in a semi-arid zone, Nigeria. J Am Sci. 2006;2(2):28–34.
  • Wang W, Sarkodie F, Danso K, et al. Seroprevalence of west nile virus in Ghana. Viral Immunol. 2009;22:17–22.19210224
  • Pourrut X, Nkoghé D, Paweska J, Leroy E. First serological evidence of West Nile virus in human rural populations of Gabon. Virol J. 2010;7:132. doi:10.1186/1743-422X-7-13220565765
  • Nur YA, Groen J, Heuvelmans H, Tuynman W, Copra C, Osterhaus AD. An outbreak of West Nile fever among migrants in Kisangani, Democratic Republic of Congo. Am J Trop Med Hyg. 1999;61:885–888. doi:10.4269/ajtmh.1999.61.88510674664
  • Piron M, Plasencia A, Fleta-Soriano E, et al. Low seroprevalence of West Nile Virus in Blood Donors from Catalonia, Spain. Vector Borne Zoonotic Dis. 2015;15(12):782–784. doi:10.1089/vbz.2015.178726581013
  • Mostashari F, Bunning ML, Kitsutani PT, et al. Epidemic West Nile encephalitis, New York, 1999: results of a household-based seroepidemiological survey. Lancet. 2001;358(9278):261–264. doi:10.1016/S0140-6736(01)05480-011498211
  • Hadjichristodoulou C, Pournaras S, Mavrouli M, et al. West Nile Virus seroprevalence in the Greek Population in 2013: a nationwide cross-sectional survey. PLoS One. 2015;10(11):e0143803. doi:10.1371/journal.pone.014380326605539
  • Shaibi T, Saadawi WK, Aghila H, Annaja BB. Prevalence of IgG antibodies for the West Nile virus in human population in Tripoli, Libya. J Vector Borne Dis. 2017;54:183–186.28748841
  • Liu A, Lee V, Galusha D, et al. Risk factors for human infection with West Nile virus in Connecticut: a multi-year analysis. Int J Health Geogr. 2009;8:67. doi:10.1186/1476-072X-8-6719943935
  • CDC. WNV Antibody Testing. Available from: https://www.cdc.gov/westnile/healthcareproviders/healthCareProviders-Diagnostic.html. Accessed 825, 2019.
  • Turell MJ, O’Guinn ML, Dohm DJ, Jones JW. Vector competence of North American mosquitoes (Diptera: culicidae) for West Nile virus. J Med Entomol. 2001;38(2):130–134. doi:10.1603/0022-2585-38.2.13011296813